Abstract
Carboxypeptidase U circulates in plasma in an inactive form and becomes activated during clotting. Once activated, carboxypeptidase U inhibits fibrinolysis, which delays clot lysis.
| Original language | English (US) |
|---|---|
| Title of host publication | xPharm |
| Subtitle of host publication | The Comprehensive Pharmacology Reference |
| Publisher | Elsevier Inc. |
| Pages | 1-5 |
| Number of pages | 5 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - 2007 |
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics